Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6609 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-04-03 (femtechinsider.com)
What's New in Femtech This Week? (April 3, 2025) | Femtech Insider
Every Thursday we send out a curated newsletter on all things femtech and women's health innovation. This is an excerpt from the latest edition. If you'd like to subscribe, you can do so at the bottom of this page. Highlights Women's healthtech company Fizimed raises €4M for international expansion. PE Firm Astorg combined multiple reproductive health medtech businesses; launches Nexpring Health.
Read more
2025-03-24 (bizjournals.com)
Biogen to move HQ to new tower in MIT Kendall developmentTipping plummets in Central Florida as restaurant workers face 46% dropTilman Fertitta plans to resign as Landry's CEO to take Trump roleThese Mass. colleges have the highest earning potentialSports and entertainment mogul buys mansion in Cherry Hills VillageCenter for Forensic Science Research lays off 30% of staff amid federal funding uncertaintyGenetic testing pioneer 23andMe 's saga takes a turn for the worse- San Francisco Business TimesSeattle
1 day ago
Read more
2024-09-25 (mypharma-editions.com)
Friedreich's ataxia: Biogen launches an inventory of the care pathway with the Brain Institute and the support of the AFAF
On the occasion of International Ataxia Day, Biogen France, a pioneering biotechnology company in scientific innovation in diseases without a solution, announces the production of an inventory of the health journey of patients living with it. Friedreich's ataxia4, as well as
Read more
2024-07-06 (followin.io)
Weekly Dose of Optimism #101
Today’s Not Boring is brought to you by… Eight Sleep
Read more
2024-02-14 (statnews.com)
Replicate's srRNA rabies vaccine effective in Phase 1
Replicate Bioscience's self-replicating RNA rabies vaccine induced strong immune responses in a Phase 1 clinical trial, even at extremely low doses. Notably, the doses contained fractions of the volume found in the mRNA Covid shot.
Read more
2023-12-04 (necn.com)
Biotech startup raises nine-figure round, one of the biggest of 2023
Biotech startup raises nine-figure round, one of the biggest of 2023
Read more
2023-07-05 (handelszeitung.ch)
Pharmaceutical bosses are on the brakes when it comes to new drugs
More and more corporations are going over the books with their pipelines. Innovation-hostile legislative changes in the USA and Europe are to blame.
Read more
2019-11-05 (siliconangle.com)
Workday buys e-sourcing solutions startup Scout RFP for $540M
Workday buys e-sourcing solutions startup Scout RFP for $540M - SiliconANGLE
Read more
2018-07-24 (fiercebiotech.com)
Biogen pays $27.5M upfront for 2 AliveGen muscle drugs
Biogen has bolted on a couple of early-stage drug candidates for neuromuscular diseases via a $535 million deal with California startup AliveGen. | Biogen has bolted on a couple of early-stage drug candidates for neuromuscular diseases via a $535 million deal with California startup AliveGen.
Read more
(firmenpresse.de)
Start SMArt! School, training, studies and career: young people with SMA pursue their career
"Exchange moves", the virtual discussion group for people with SMA openness, creativity, courage, patience, assertiveness... Anyone who plays...
Read more